| NCT06685692 | A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1) | RECRUITING | PHASE2 | 2024-11-04 | 2025-12-31 | 2025-12-31 |
| NCT06493604 | A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2024-06-24 | 2025-02-27 | 2025-02-27 |
| NCT06424444 | A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2024-04-29 | 2024-11-03 | 2024-11-03 |
| NCT06389214 | A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2024-04-09 | 2024-06-11 | 2024-06-11 |
| NCT05717920 | A Clinical Trial in Subjects With Atopic Dermatitis (Part 1) | COMPLETED | PHASE2 | 2023-02-15 | 2023-11-21 | 2023-11-21 |
| NCT05599815 | Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome | WITHDRAWN | PHASE2 | 2023-01 | 2023-05 | 2023-05 |
| NCT05392179 | A Study in Subjects With Retinitis Pigmentosa | COMPLETED | PHASE2 | 2022-07-14 | 2023-06-23 | 2023-06-23 |
| NCT05392192 | A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough | COMPLETED | PHASE2 | 2022-04-07 | 2023-04-13 | 2023-04-13 |
| NCT05424549 | A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease | COMPLETED | PHASE2 | 2022-03-09 | 2022-05-09 | 2022-05-09 |
| NCT05234554 | The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis | COMPLETED | PHASE3 | 2022-01-21 | 2023-04-22 | 2023-04-22 |
| NCT05487404 | A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels | COMPLETED | PHASE1, PHASE2 | 2021-11-15 | 2022-05-29 | 2022-05-29 |
| NCT05102409 | An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber | COMPLETED | PHASE2 | 2021-09-09 | 2021-10-25 | 2021-10-25 |
| NCT05062330 | The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2021-08-28 | 2022-03-04 | 2022-03-04 |
| NCT04971031 | A Clinical Trial to Assess Subjects With Dry Eye Disease. | COMPLETED | PHASE2 | 2021-06-15 | 2021-09-08 | 2021-09-08 |
| NCT04908514 | A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis | COMPLETED | PHASE2 | 2021-05-07 | 2022-01-21 | 2022-01-21 |
| NCT04847544 | A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19. | COMPLETED | PHASE2 | 2021-03-31 | 2021-10-15 | 2021-10-15 |
| NCT04735393 | A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2021-01-26 | 2022-10-11 | 2022-10-11 |
| NCT04728711 | A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC) | COMPLETED | PHASE2 | 2021-01-09 | 2022-01-18 | 2022-01-18 |
| NCT04674358 | The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease | COMPLETED | PHASE2, PHASE3 | 2020-11-21 | 2021-09-12 | 2021-09-12 |
| NCT04207736 | The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis. | COMPLETED | PHASE3 | 2019-12-05 | 2021-02-16 | 2021-02-16 |
| NCT04136366 | The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy | COMPLETED | PHASE3 | 2019-11-15 | 2022-06-14 | 2022-06-14 |
| NCT03916042 | A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease | COMPLETED | PHASE2 | 2019-04-23 | 2019-11-22 | 2019-11-22 |
| NCT03879863 | The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease | COMPLETED | PHASE3 | 2019-04-16 | 2019-10-04 | 2019-10-04 |
| NCT03709121 | A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber | COMPLETED | PHASE1, PHASE2 | 2018-10-02 | 2019-03-20 | 2019-03-20 |
| NCT03660878 | A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis | COMPLETED | PHASE1, PHASE2 | 2018-09-08 | 2019-11-19 | 2019-11-19 |
| NCT03445650 | RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS) | COMPLETED | PHASE3 | 2018-07-18 | 2020-01-18 | 2020-01-18 |
| NCT03494504 | ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis | COMPLETED | PHASE3 | 2018-03-30 | 2018-11-05 | 2018-11-05 |
| NCT03404115 | A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease | COMPLETED | PHASE2 | 2018-01-02 | 2018-07-11 | 2018-07-11 |
| NCT03162783 | A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome | COMPLETED | PHASE2 | 2017-05-15 | 2017-07-06 | 2017-07-06 |
| NCT03131154 | SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis. | COMPLETED | PHASE3 | 2017-04-26 | 2019-04-26 | 2019-04-19 |
| NCT03012165 | A Study of ADX-102 in Subjects With Allergic Conjunctivitis | COMPLETED | PHASE2 | 2016-12 | 2017-05 | 2017-05 |
| NCT02578914 | A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis | COMPLETED | PHASE2 | 2015-08 | 2015-12 | 2015-12 |
| NCT02402309 | A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS) | COMPLETED | PHASE2 | 2015-03 | 2016-06 | 2016-05 |
| NCT02406209 | A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis | COMPLETED | PHASE2 | 2015-03 | 2016-04 | 2016-04 |